Aurobindo Pharma receives USFDA approval to market potassium chloride
Aurobindo Pharma Ltd has received USFDA approval to market potassium chloride tablets of 600 mg and 750 mg in the US market. The tablet, a […]
Month: December 2018
Sun Pharma receives USFDA approval for Elepsia XR
Sun Pharmaceutical has received USFDA approval for Elepsia XR, an antiepileptic drug in US markets. The company has received this approval through one of its […]
Strides Pharma Science receives USFDA approval for Polyethylene Glycol 3350
Strides Pharma Science has received final USFDA approval to market laxative Polyethylene Glycol 3350 and Electrolytes for Oral Solution. The company has received this approval […]
Cadila Group has received USFDA approval for Doxycycline Hyclate and Febuxostat
Zydus Cadila has received final USFDA approval to market Doxycycline Hyclate delayed-release tablets which are used to treat bacterial infections. The drug will be marketed […]
Lupin signs agreement with AbbVie for MALT1 inhibitor programme
Lupin has tied up with – AbbVie – a global biopharmaceutical company to develop new drugs. AbbVie has signed an agreement to get license rights […]
Aurobindo Pharma receives USFDA approval for Vecuronium Bromide injection
Aurobindo Pharma has received final USFDA approval to manufacture and market Vecuronium Bromide Injection, 10mg and 20mg for the US markets. The drug Vecuronium Bromide […]
Bengal Chemicals plans expansion programme
Bengal Chemicals and Pharma is planning to expand its manufacturing facility in Panihati in West Bengal. The project involves setting up of production facilities to […]
Cadila Group receives USFDA approval for Clindamycin Phosphate and Benzoyl Peroxide
Zydus Cadila has received the final USFDA approval to market Clindamycin Phosphate and Benzoyl Peroxide gel in US markets. The combination gel is used in […]
Alembic raises ₹ 3500 million by private placement
Alembic Pharmaceuticals has raised ₹3500 million through allotment of non-convertible debentures (NCDs) on private placement basis. The NCD committee of Alembic Pharmaceuticals Ltd has allotted […]
Rusan Pharma launches APOSAN drug in India
Rusan Pharma has launched APOSAN -Apomorphine Hydrochloride (HCl), in India after approval from the DCG(I). The drug APOSAN is used for the treatment of motor […]